News Results
There are 286,406 News Results
Aug 26, 2017
BARCELONA, Spain, Aug. 27, 2017 /PRNewswire/ -- Results from the pivotal Phase 3 COMPASS study found that the XARELTO(®) (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin 100 mg...
Aug 30, 2017
WOODCLIFF LAKE, N.J., Aug. 31, 2017 /PRNewswire/ -- Eisai Inc. will present data from its lenvatinib (marketed as Lenvima(®)) clinical trial program in four difficult-to-treat cancers at the European Society...
Sep 5, 2017
NEW YORK, September 6, 2017 /PRNewswire/ -- Merger and acquisition activity has played a massive role in the formation of the pharmaceutical industry as it exists today. Historic deals, like...
Sep 9, 2017
EAST HANOVER, N.J., Sept. 10, 2017 /PRNewswire/ -- Novartis today announced results from a Phase III study of 870 patients with stage III BRAF V600E/K mutation-positive melanoma after complete surgical...
Sep 12, 2017
EAST HANOVER, N.J., Sept. 13, 2017 /PRNewswire/ -- Novartis announced today first of its kind Phase III data showing Cosentyx(®) (secukinumab) delivered high and long-lasting skin clearance in patients with...
Sep 18, 2017
LONDON, September 19, 2017 /PRNewswire/ -- The U.S. marijuana market is forecast to reach $25 billion by 2020 [ http://www.prnewswire.com/news-releases/greenwave-advisors-increases-us-... ] , with recreational use currently legalized in only two...
Sep 19, 2017
ARLINGTON, Va., Sept. 20, 2017 /PRNewswire-USNewswire/ -- Capital Impact Partners announced today that it provided $75 million in project financing during the second quarter of 2017. This represents the largest...
Sep 20, 2017
DARMSTADT, Germany and NEW YORK, USA, September 21, 2017 /PRNewswire/ -- Not intended for UK-based media - First approved immunotherapy for rare and aggressive skin cancer in the European Union,...
Sep 20, 2017
LONDON, September 21, 2017 /PRNewswire/ -- Twenty years ago, it was vilified as a 'gateway drug'. Now, cannabis has grown into a big business, with the potential to become even...
